NMT1 inhibition modulates breast cancer progression through stress-triggered JNK pathway

Lu Deng1,2, Xinlei Gao2, Bingjie Liu1,2

  • 1Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences; Shanghai Medical College; Key Laboratory of Breast Cancer in Shanghai; Innovation Center for Cell Signaling Network; Cancer Institutes, Fudan University, 200032, Shanghai, China.

Cell Death & Disease
|November 18, 2018
PubMed

Insights

Targeting N-myristoyltransferase 1 (NMT1) inhibits breast cancer progression by inducing oxidative and ER stress, activating pathways that promote autophagy. This offers a new strategy for treating breast cancer, particularly triple-negative breast cancer (TNBC).

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cellular Signaling

Background:

  • Myristoylation is a crucial post-translational modification implicated in cancer development.
  • Targeting myristoylation presents a potential therapeutic strategy for cancer, but mechanisms remain unclear.
  • N-myristoyltransferase 1 (NMT1) plays a role in myristoylation and cancer.

Purpose of the Study:

  • To investigate the role of NMT1 in breast cancer progression.
  • To elucidate the mechanisms by which NMT1 inhibition affects cancer cells.
  • To explore the potential of targeting NMT1 as a breast cancer therapy.

Main Methods:

  • Genetic inhibition of NMT1 in breast cancer cells (in vitro and in vivo).
  • Analysis of reactive oxygen species (ROS) and endoplasmic reticulum (ER) stress.
  • Investigation of protein degradation, mitochondrial function, and JNK/autophagy pathways.

Main Results:

  • NMT1 inhibition suppressed breast cancer initiation, proliferation, and invasion.
  • A feedback loop between NMT1, ROS, and oxidative stress was identified.
  • NMT1 inhibition induced protein degradation, ER stress, and ROS production, activating JNK and autophagy, which inhibited cancer progression, especially in triple-negative breast cancer (TNBC).

Conclusions:

  • NMT1 is a critical regulator of breast cancer cell behavior.
  • Targeting NMT1 induces a cascade of cellular stresses (oxidative, ER) leading to autophagy.
  • NMT1 inhibition represents a promising preclinical strategy for breast cancer treatment, particularly TNBC.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.8K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.1K
Responses to Salt Stress02:02

Responses to Salt Stress

Salt stress—which can be triggered by high salt concentrations in a plant’s environment—can significantly affect plant growth and crop production by influencing photosynthesis and the absorption of water and nutrients.
14.6K
C4 Pathway and CAM01:27

C4 Pathway and CAM

Most plants use the C3 pathway for carbon fixation. However, some plants, such as sugar cane, corn, and cacti that grow in hot conditions, use alternative pathways to fix carbon and conserve energy loss due to photorespiration. Photorespiration is the process that occurs when the oxygen concentration is high. Under such conditions, the rubisco enzyme in the Calvin cycle binds O2 instead of CO2, which halts photosynthesis and consumes energy.
C4 Pathway
The C4 pathway is used by plants such as...
49.2K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.4K